ZHOU Wenyuan,REN Jun,JI Yuan, et al. the roles of N-acetyl galactosyltransferase-6 in proliferation and migration of breast cancer cell MCF-7[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2017, 47(12): 864-868,874.
Abstract：Objective: To explore the effects of N-acetyl galactosyltransferase-6 (GALNT6) on the abilities of proliferation and migration in MCF-7 cells. Methods: Generated sh-GALNT6 to knockdown the GALNT6 expression in MCF-7 cells. The CCK8 assay, plate clone formation assay, cell cycle test and would healing assay were performed to detect the proliferation and migration activity of MCF-7 cells. The expression of PCNA, cyclinD1 and MUC1 as a downstream of GALNT6 were measured by Western blot. Results: The stable transfected sh-GALNT6 MCF-7 cell lines were constructed successfully. Down-regulation of GALNT6 could inhibit the proliferation and migration of MCF-7 cells. The expressions of PCNA, cyclinD1, and MUC1 were reduced in cells after they were transfected with sh-GALNT6. Conclusion: GALNT6 might play important roles in proliferation and migration of breast cancer, and it is also a potential molecular therapeutic target.
[1] SMITH R A, MANASSARAM-BAPTISTE D, BROOKS D, et al. Cancer screening in the United States 2015: a review of current American cancer society guidelines and current issues in cancer screening[J]. CA Cancer J Clin , 2015, 65(1): 30-54.
[2] YANG M D, CHANG W S, TSAI C W, et al. Inhibitory effects of AVEMAR on proliferation and metastasis of oral cancer cells[J].Nutr Cancer, 2016, 68(3): 473-480.
[3] PARK J H, NISHIDATE T, KIJIMA K, et al. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis[J]. Cancer Res, 2010, 70(7): 2759-2769.
[4] GAO Y, LIU Z, FENG J,et al. Expression pattern of polypeptide N-acetylgalactosaminyltransferase-10 in gastric carcinoma[J].Oncol Lett , 2013, 5(1): 113-116.
[5] PARK J H, NISHIDATE T, KIJIMA K, et al. Gritical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis[J]. Cancer Res, 2010, 70(7): 2759-2769.
[6] SCHJOLDAGER K T, CLAUSEN H. Site-specific protein O-glycosylation modulates proprotein processing - deciphering specific functions of the large polypeptide GalNAc-transferase gene family[J].Biochim Biophys Acta, 2012, 1820(12): 2079-2094.
[7] VITIAZEVA V, KATTLA J J, FLOWERS S A, et al. The O-linked glycome and blood group antigens ABO on mucin-type glycoproteins in mucinous and serous epithelial ovarian tumors[J].PLoS One, 2015, 10(6): e0130197.
[8] ZHANG Q, CHEN X, ZHANG X, et al. Knockdown of TMEM14A expression by RNAi inhibits the proliferation and invasion of human ovarian cancer cells[J]. Biosci Rep, 2016, 36(1):e00298.
[9] CHIU K Y, WU C C, CHIA C H, et al. Inhibition of growth, migration and invasion of human bladder cancer cells by antrocin, a sesquiterpene lactone isolated from Antrodia cinnamomea, and its molecular mechanisms[J].Cancer Lett, 2016, 373(2): 174-184.
[10] KUBBEN F J, PEETERS-HAESEVOETS A, ENGELS L G, et al. Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferation[J].Gut,1994, 35(4): 530-535.
[11] ARNOLD A, PAPANIKOLAOU A. Cyclin D1 in breast cancer pathogenesis[J].J Clin Oncol, 2015, 23(18): 4215-4224.
[12] BROCKHAUSEN I. Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions[J].EMBO Rep, 2006, 7(6): 599-604.
[13] REMMERS N, ANDERSON J, LINDE E, et al. Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer[J].Clin Cancer Res, 2013, 19(8): 1981-1993.
[14] KIM Y S, GUM J JR, BROCKHAUSEN I. Mucin glycoproteins in neoplasia[J]. Glycoconj J, 1996, 13(5): 693-707.
